You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 6, June 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Plasma Concentrations of Fibrinopeptide A and Fibrinopeptide Bβ15-42 in Glomerulonephritis and the Nephrotic Syndrome

Shigeo Tomura, MD; Yashuo Oono; Renjiro Kuriyama, MD; Jugoro Takeuchi, MD

Arch Intern Med. 1985;145(6):1033-1035.


Abstract

• Plasma fibrinopeptide A (FPA) and fibrinopeptide Bβ15-42 concentrations were determined by radioimmunoassay in 46 patients with glomerulonephritis and the nephrotic syndrome. An increase in plasma FPA and Bβ15-42 levels was noted in these patients; this increase was marked in the nephrotic patients. There was a positive correlation in these patients between plasma FPA and Bβ15-42 levels. The Bβ15-42/FPA ratio was significantly higher in nonnephrotic patients compared with controls. Intravascular coagulation with subsequent fibrinolysis to regulate fibrin formation may occur in patients. A positive correlation was found between plasma Bβ15-42 level and serum urea nitrogen or serum creatinine concentration, suggesting that plasma Bβ15-42 level is influenced not only by plasmin action, but also by renal dysfunction.

(Arch Intern Med 1985;145:1033-1035)



Author Affiliations

From the Department of Internal Medicine, Tokyo Medical and Dental University (Drs Tomura, Kuriyama, and Takeuchi), and the Department of Clinical Chemistry, Special Reference Laboratory, Tokyo (Mr Oono). Dr Tomura is now with the Division of Nephrology, Department of Medicine, Harbor-UCLA Medical Center, Torrance, Calif.


Footnotes

Accepted for publication July 24, 1984.

Reprint requests to C-1 Annex, Division of Nephrology, Department of Medicine, Harbor-UCLA Medical Center, 1000 Carson St, Torrance, CA 90509 (Dr Tomura).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.